KPRX
KIORA PHARMACEUTICALS INC
+0.05 (+1.92%)2.65USD5.3K成交股數11.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00 | 0.00-100% | 0.00-100% | 0.00 | 0.00 | 20K | 16.0M | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 2.1M | 2.9M | 2.7M | 2.6M | 2.5M | 2.2M | 2.0M | 1.7M | 1.1M | 1.1M | 1.4M |
| 銷售管理費用 | 1.4M | 1.6M | 1.5M | 1.4M | 1.4M | 1.5M | 1.4M | 1.5M | 1.3M | 881K | 1.4M | 1.1M |
| 營業利益 | −2.2M-8% | −2.5M+8% | −7.3M+103% | −794K-69% | −2.4M-118% | −2.3M+10% | −3.6M-39% | −2.5M-3% | 13.2M | −2.1M | −5.9M | −2.6M |
| 營業利益率 | – | – | – | – | – | – | – | -12,724.4% | 82.6% | – | – | – |
| 稅後淨利 | −2.1M-3% | −2.4M+10% | 4.3M-226% | 27K-101% | −2.2M-116% | −2.2M-121% | −3.4M-41% | −2.2M-15% | 13.5M | 10.2M | −5.8M | −2.6M |
| 淨利率 | – | – | – | – | – | – | – | -11,108.2% | 84.1% | – | – | – |
| 稀釋 EPS | -0.34-37% | -0.58+12% | -1.59+96% | 0.01-102% | -0.54-116% | -0.52-94% | -0.81-89% | -0.53-93% | 3.46 | -8.80 | -7.30 | -7.15 |
| 稀釋股數 | 6.2M | 4.2M | 4.1M | 4.4M | 4.0M | 4.2M | 4.2M | 4.2M | 3.9M | 538K | 790K | 366K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.1M | 11.0M | 8.7M | 5.5M | 1.0M | 3.8M | 5.6M | 6.6M | 31.3M | 2.5M | 5.4M | 8.0M |
| 應收帳款 | 1.1M | 1.5M | 1.5M | 1.2M | 2.4M | 1.3M | 1.8M | 1.3M | 190K | 0.00 | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 23.8M | 21.2M | 24.3M | 29.9M | 31.9M | 34.0M | 38.5M | 40.8M | 42.4M | 13.7M | 15.9M | 19.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 6.9M | 7.3M | 8.1M | 7.5M | 9.8M | 10.3M | 8.5M | 7.7M | 7.5M | 7.6M | 7.8M | 6.2M |
| 股東權益 | 16.9M | 13.9M | 16.1M | 22.4M | 22.1M | 23.7M | 30.0M | 33.1M | 34.9M | 6.1M | 8.1M | 13.6M |
| 負債比 | 29.1% | 34.4% | 33.5% | 25.0% | 30.7% | 30.3% | 22.0% | 18.9% | 17.8% | 55.4% | 49.0% | 31.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.2M+17% | – | – | – | −2.7M | – | – | 13.6M | – | – | – |
| 資本支出 | – | 5K | – | – | – | 0.00 | – | – | – | – | – | – |
| 自由現金流 | – | −3.2M+17% | – | – | – | −2.7M | – | – | – | – | – | – |
| 折舊攤銷 | – | 11K | – | – | – | 318.00 | – | – | 5K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −11K | –% | -2.64 | −10.1M |
| FY2024 | 16.0M | – | 4K | 0.0% | 0.87 | 8.6M |
| FY2023 | 0.00 | – | −13K | –% | -24.25 | −9.6M |
| FY2022 | – | – | −13.6M | –% | -18.55 | −10.4M |
| FY2021 | 0.00 | -100.0% | −13.8M | –% | -57.12 | −10.7M |
| FY2020 | 12K | -99.6% | −6.9M | -56,901.7% | -1.49 | −7.3M |
| FY2019 | 2.7M | +62.5% | −7.1M | -264.2% | -2.23 | −8.2M |
| FY2018 | 1.7M | – | −10.8M | -654.2% | -4.57 | −10.9M |